Kate Seib PhD

Dr Seib is a Group Leader and NHMRC Career Development Fellow at the Institute for Glycomics, Griffith University. She completed a PhD in microbiology in 2004 from the University of Queensland and worked briefly as a Postdoctoral Researcher in Australia. She then spent 6.5 years at Novartis Vaccines as a Postdoctoral Researcher and Project Leader. During this time she was part of the team that developed the recently licensed serogroup B meningococcal vaccine.

Dr Seib returned to Australia in 2012 and is currently a Research Leader and NHMRC Career Development Fellow at the Institute for Glycomics, Griffith University. Her research is focused on understanding the processes involved in host colonisation and disease, with the aim to identify therapeutic targets of human, mucosal pathogens including Moraxella catarrhalis, Neisseria gonorrhoeae (causes the sexually transmitted infection gonorrhea, which can lead to infertility) and Neisseria meningitidis.